title: Platelet-activating factor primes human eosinophil generation of superoxide.
abstract: Platelet-activating factor (PAF) is a potent inflammatory mediator that can cause airway obstruction and hyperresponsiveness; these processes are also associated with pulmonary eosinophilia, suggesting a link between these two events. Thus, PAF's interaction with eosinophils may provide a mechanism for airway damage. However, direct in vitro activation of eosinophils by PAF requires concentrations that are likely higher than those achieved in vivo. As a result, we investigated whether lower, more physiologic concentrations of PAF could prime eosinophils for subsequent activation to another receptor-stimulated factor, in this case formylmethionylleucylphenylalanine (FMLP). To test this hypothesis, eosinophils were preincubated (1 and 15 min) with low concentrations of PAF (1 x 10(-8) and 1 x 10(-10) M); this exposure to PAF resulted in enhanced generation of superoxide anion to FMLP stimulation. Moreover, similar concentrations of PAF decreased eosinophil density and increased expression of cell surface CR3 receptors. Finally, low, nonactivating concentrations of PAF (1 x 10(-10) to 1 x 10(-8) M) caused transient increases in eosinophil cytosolic free Ca2+ concentrations. Collectively, these responses are consistent with the hypothesis that short-term exposure to low concentrations of PAF primes eosinophils to cause an enhanced inflammatory response upon subsequent activation to another receptor agonist. The consequences of this PAF-associated phenomenon can produce an enhanced inflammatory response and airway injury.
authors.affiliation: Department of Medicine, University of Wisconsin Medical School, Madison.
authors.forename: E M
authors.initials: EM
authors.lastname: Zoratti
authors.forename: J B
authors.initials: JB
authors.lastname: Sedgwick
authors.forename: M E
authors.initials: ME
authors.lastname: Bates
authors.forename: R F
authors.initials: RF
authors.lastname: Vrtis
authors.forename: K
authors.initials: K
authors.lastname: Geiger
authors.forename: W W
authors.initials: WW
authors.lastname: Busse
mesh_terms: D000328:Adult; D002118:Calcium / Q000097:blood; D004804:Eosinophils / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D007958:Leukocyte Count / Q000187:drug effects; D016177:Macrophage-1 Antigen / Q000187:drug effects / Q000378:metabolism; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology; D010972:Platelet Activating Factor / Q000494:pharmacology*; D013481:Superoxides / Q000097:blood*
chemical_list: D016177:Macrophage-1 Antigen; D010972:Platelet Activating Factor; D013481:Superoxides; D009240:N-Formylmethionine Leucyl-Phenylalanine; D002118:Calcium